{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T13:03:08Z","timestamp":1792069388675,"version":"4.4.0"},"reference-count":39,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T00:00:00Z","timestamp":1621296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>The treatment of bipolar depression is hampered by the inadequate efficacy of antidepressants, moderate effect of mood stabilizers, and the side effects of some second-generation antipsychotics. There is limited evidence to date regarding the antidepressant effects of memantine in bipolar depression. The aim of the article was to provide a short review of preclinical and clinical studies on the antidepressant effect of memantine, and to present the case of a bipolar depression patient successfully treated with memantine. The described patient with bipolar disorder was unsuccessfully treated with two mood stabilizers. The addition of memantine at a dose of 20 mg\/d to the treatment with lamotrigine and valproic acid resulted in a reduction in the severity of depression measured on the HDRS-17 scale by 35%, and by 47.1% after 7 weeks. The discussion presents experimental evidence for the antidepressant effect of memantine, as well as data from clinical trials in recurrent and bipolar depression. The presented case is the second report in the medical literature showing the antidepressant effect of memantine as an add-on treatment for bipolar depression. The described case and literature analysis indicate that memantine may be an effective and safe method of augmentation of mood stabilizing therapy in bipolar depression.<\/jats:p>","DOI":"10.3390\/ph14050481","type":"journal-article","created":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T23:34:46Z","timestamp":1621380886000},"page":"481","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Possible Antidepressant Effects of Memantine\u2014Systematic Review with a Case Study"],"prefix":"10.3390","volume":"14","author":[{"given":"Marek","family":"Krzystanek","sequence":"first","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, Clinic of Psychiatric Rehabilitation, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Zio\u0142owa 45\/47, 40-635 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8073-6664","authenticated-orcid":false,"given":"Stanis\u0142aw","family":"Surma","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, Clinic of Psychiatric Rehabilitation, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Zio\u0142owa 45\/47, 40-635 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artur","family":"Pa\u0142asz","sequence":"additional","affiliation":[{"name":"Department of Histology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Medyk\u00f3w 18, 40-752 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Roma\u0144czyk","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, Clinic of Psychiatric Rehabilitation, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Zio\u0142owa 45\/47, 40-635 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5984-3358","authenticated-orcid":false,"given":"Krzysztof","family":"Krysta","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, Clinic of Psychiatric Rehabilitation, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Zio\u0142owa 45\/47, 40-635 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,5,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.psc.2015.09.001","article-title":"Treatment of Bipolar Depression","volume":"39","author":"Post","year":"2016","journal-title":"Psychiatr. Clin. N. Am."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/acps.12712","article-title":"Dopaminergic agents in the treatment of bipolar depression: A systematic review and meta-analysis","volume":"135","author":"Szmulewicz","year":"2017","journal-title":"Acta Psychiatr. Scand."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1523\/JNEUROSCI.4262-04.2005","article-title":"Amantadine Inhibits NMDA Receptors by Accelerating Channel Closure during Channel Block","volume":"25","author":"Blanpied","year":"2005","journal-title":"J. Neurosci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2174\/138945007780618472","article-title":"Pathologically-Activated Therapeutics for Neuroprotection: Mechanism of NMDA Receptor Block by Memantine and S-Nitrosylation","volume":"8","author":"Lipton","year":"2007","journal-title":"Curr. Drug Targets"},{"key":"ref_5","first-page":"515","article-title":"Mechanism of NMDA receptor channel block by MK-801 and memantine","volume":"556","author":"Song","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.coph.2005.09.007","article-title":"Mechanism of action of memantine","volume":"6","author":"Johnson","year":"2006","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/mp.2016.187","article-title":"Blockade of the KATP channel Kir6.2 by memantine represents a novel mechanism relevant to Alzheimer\u2019s disease therapy","volume":"23","author":"Moriguchi","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1124\/jpet.110.174458","article-title":"Activation of Brain Histaminergic Neurotransmission: A Mechanism for Cognitive Effects of Memantine in Alzheimer\u2019s Disease","volume":"336","author":"Motawaj","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.neuint.2010.05.010","article-title":"Memantine depresses glutamate release through inhibition of voltage-dependent Ca2+ entry and protein kinase C in rat cerebral cortex nerve terminals: An NMDA receptor-independent mechanism","volume":"57","author":"Lu","year":"2010","journal-title":"Neurochem. Int."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.neulet.2008.02.027","article-title":"Memantine increases brain production of kynurenic acid via protein kinase A-dependent mechanism","volume":"435","author":"Kloc","year":"2008","journal-title":"Neurosci. Lett."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s12035-014-8875-6","article-title":"Protection of Radial Glial-Like Cells in the Hippocampus of APP\/PS1 Mice: A Novel Mechanism of Memantine in the Treatment of Alzheimer\u2019s Disease","volume":"52","author":"Sun","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3233\/JAD-161251","article-title":"A Meta-Analysis of Memantine for Depression","volume":"57","author":"Kishi","year":"2017","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1399-5618.2011.00971.x","article-title":"Early antidepressant effect of memantine during augmentation of lamotrigine inadequate response in bipolar depression: A double-blind, randomized, placebo-controlled trial","volume":"14","author":"Anand","year":"2012","journal-title":"Bipolar Disord."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1017\/S1461145713000825","article-title":"Genotype variant associated with add-on memantine in bipolar II disorder","volume":"17","author":"Lee","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"421","DOI":"10.4306\/pi.2013.10.4.421","article-title":"A 10-Week Memantine Treatment in Bipolar Depression: A Case Report. Focus on Depressive Symptomatology, Cognitive Parameters and Quality of Life","volume":"10","author":"Strzelecki","year":"2013","journal-title":"Psychiatry Investig."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1365-2125.2012.04398.x","article-title":"Bayesian model of Hamilton Depression Rating Score (HDRS) with memantine augmentation in bipolar depression","volume":"75","author":"Stevens","year":"2013","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Krzystanek, M., and Pa\u0142asz, A. (2020). Possibility of a New Indication for Amantadine in the Treatment of Bipolar Depression\u2014Case Series Study. Pharmaceuticals, 13.","DOI":"10.3390\/ph13100326"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1600-0773.1993.tb01351.x","article-title":"Potential Antidepressive Properties of Amantadine, Memantine and Bifemelane","volume":"72","author":"Moryl","year":"1993","journal-title":"Pharmacol. Toxicol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/S0028-3908(02)00055-2","article-title":"Synergistic effect of uncompetitive NMDA receptor antagonists and antidepressant drugs in the forced swimming test in rats","volume":"42","author":"Skuza","year":"2002","journal-title":"Neuropharmacology."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.neulet.2005.10.057","article-title":"Involvement of PKA, MAPK\/ERK and CaMKII, but not PKC in the acute antidepressant-like effect of memantine in mice","volume":"395","author":"Almeida","year":"2006","journal-title":"Neurosci. Lett."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.brainresbull.2009.11.013","article-title":"Neurochemical and behavioural effects of acute and chronic memantine administration in rats: Further support for NMDA as a new pharmacological target for the treatment of depression?","volume":"81","author":"Stringari","year":"2010","journal-title":"Brain Res. Bull."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.neuroscience.2011.03.026","article-title":"Possible antidepressant effects and mechanisms of memantine in behaviors and synaptic plasticity of a depression rat model","volume":"182","author":"Quan","year":"2011","journal-title":"Neuroscience"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.bbr.2011.02.024","article-title":"Ketamine plus imipramine treatment induces antidepressant-like behavior and increases CREB and BDNF protein levels and PKA and PKC phosphorylation in rat brain","volume":"221","author":"Stringari","year":"2011","journal-title":"Behav. Brain Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.brainresbull.2016.11.003","article-title":"Effect of co-administration of memantine and sertraline on the antidepressant-like activity and brain-derived neurotrophic factor (BDNF) levels in the rat brain","volume":"128","author":"Amidfar","year":"2017","journal-title":"Brain Res. Bull."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.pharep.2017.12.007","article-title":"Effectiveness of memantine on depression-like behavior, memory deficits and brain mRNA levels of BDNF and TrkB in rats subjected to repeated unpredictable stress","volume":"70","author":"Amidfar","year":"2018","journal-title":"Pharmacol. Rep."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"152200","DOI":"10.1016\/j.comppsych.2020.152200","article-title":"Alleviation of cognitive deficits and high copper levels by an NMDA receptor antagonist in a rat depression model","volume":"102","author":"Li","year":"2020","journal-title":"Compr. Psychiatry"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1176\/appi.ajp.163.1.153","article-title":"A Double-Blind, Placebo-Controlled Study of Memantine in the Treatment of Major Depression","volume":"163","author":"Zarate","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/WNF.0b013e3180314ae7","article-title":"An Open-label, Flexible-Dose Study of Memantine in Major Depressive Disorder","volume":"30","author":"Ferguson","year":"2007","journal-title":"Clin. Neuropharmacol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"392","DOI":"10.4088\/JCP.v69n0308","article-title":"Double-blind, randomized comparison of memantine and escitalopram for the treatment of major depressive disorder comorbid with alcohol dependence","volume":"69","author":"Muhonen","year":"2008","journal-title":"J. Clin. Psychiatry"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"966","DOI":"10.4088\/JCP.12m08252","article-title":"Antidepressant augmentation using the N-methyl-D-aspartate antagonist memantine: A randomized, double-blind, placebo-controlled trial","volume":"74","author":"Smith","year":"2013","journal-title":"J. Clin. Psychiatry"},{"key":"ref_31","first-page":"525","article-title":"Memantine add on to citalopram in elderly patients with depression: A double-blind placebo-controlled study","volume":"19","author":"Omranifard","year":"2014","journal-title":"J. Res. Med. Sci."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/jcpt.12469","article-title":"Effect of memantine combination therapy on symptoms in patients with moderate-to-severe depressive disorder: Randomized, double-blind, placebo-controlled study","volume":"42","author":"Amidfar","year":"2016","journal-title":"J. Clin. Pharm. Ther."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jagp.2019.08.011","article-title":"A Randomized Double-Blind Placebo-Controlled Trial of Combined Escitalopram and Memantine for Older Adults With Major Depression and Subjective Memory Complaints","volume":"28","author":"Lavretsky","year":"2020","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jad.2011.09.040","article-title":"The sustained mood-stabilizing effect of memantine in the management of treatment resistant bipolar disorders: Findings from a 12-month naturalistic trial","volume":"136","author":"Koukopoulos","year":"2012","journal-title":"J. Affect. Disord."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/WNF.0b013e318184fae2","article-title":"Memantine Efficacy and Safety in Patients with Acute Mania Associated with Bipolar I Disorder","volume":"32","author":"Keck","year":"2009","journal-title":"Clin. Neuropharmacol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/2045125313507737","article-title":"Memantine in the management of affective recurrences of bipolar disorders after the discontinuation of long-term lithium treatment: Three case histories","volume":"4","author":"Serra","year":"2013","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1524-475X.2004.04006.x","article-title":"A Process for Systematically Reviewing the Literature: Providing the Research Evidence for Public Health Nursing Interventions","volume":"1","author":"Thomas","year":"2004","journal-title":"Worldviews Evid.-Based Nurs."},{"key":"ref_39","first-page":"12","article-title":"Assessment of study quality for systematic reviews: A comparison of the Cochrane Collaboration Risk of Bias Tool and the Effective Public Health Practice Project Quality Assessment Tool: Methodological research","volume":"18","author":"Stiles","year":"2010","journal-title":"J. Eval. Clin. Pract."}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/14\/5\/481\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:03:41Z","timestamp":1760162621000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/14\/5\/481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,18]]},"references-count":39,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,5]]}},"alternative-id":["ph14050481"],"URL":"https:\/\/doi.org\/10.3390\/ph14050481","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,18]]}}}